{
  "trial_id": "NCT01502410",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, type of cancer, performance status (Lansky or Karnofsky score), absolute neutrophil count (ANC), platelet count, hemoglobin level, creatinine clearance or serum creatinine, total bilirubin, SGPT (ALT) level, PT, PTT, INR, serum lipase, serum amylase, pulse oximetry, blood pressure, pregnancy status, prior treatments (chemotherapy, radiotherapy, immunotherapy, biologic agents, monoclonal antibodies, radioiodine treatment), use of corticosteroids, use of other medications (e.g., cytochrome P450 enzyme-inducing anti-epileptic drugs, cyclosporine, tacrolimus), history of prior treatment with sorafenib, presence of metastasis to the brain, presence of hepatic encephalopathy or ascites, presence of uncontrolled infection, evidence of bleeding diathesis, presence of Gilbert syndrome, ability to comply with safety-monitoring requirements.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Male",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "type of cancer",
        "performance status (Lansky or Karnofsky score)",
        "absolute neutrophil count (ANC)",
        "platelet count",
        "hemoglobin level",
        "creatinine clearance or serum creatinine",
        "total bilirubin",
        "SGPT (ALT) level",
        "PT",
        "PTT",
        "INR",
        "serum lipase",
        "serum amylase",
        "pulse oximetry",
        "blood pressure",
        "pregnancy status",
        "prior treatments (chemotherapy, radiotherapy, immunotherapy, biologic agents, monoclonal antibodies, radioiodine treatment)",
        "use of corticosteroids",
        "use of other medications (e.g., cytochrome P450 enzyme-inducing anti-epileptic drugs, cyclosporine, tacrolimus)",
        "history of prior treatment with sorafenib",
        "presence of metastasis to the brain",
        "presence of hepatic encephalopathy or ascites",
        "presence of uncontrolled infection",
        "evidence of bleeding diathesis",
        "presence of Gilbert syndrome",
        "ability to comply with safety-monitoring requirements."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Type of Cancer, Disease Status (Relapsed/Refractory), Performance Status (Lansky/Karnofsky), Absolute Neutrophil Count (ANC), Platelet Count, Hemoglobin, Creatinine Clearance, Total Bilirubin, SGPT (ALT), PT, PTT, INR, Serum Lipase, Serum Amylase, Blood Pressure,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Type of Cancer",
        "Disease Status (Relapsed/Refractory)",
        "Performance Status (Lansky/Karnofsky)",
        "Absolute Neutrophil Count (ANC)",
        "Platelet Count",
        "Hemoglobin",
        "Creatinine Clearance",
        "Total Bilirubin",
        "SGPT (ALT)",
        "PT",
        "PTT",
        "INR",
        "Serum Lipase",
        "Serum Amylase",
        "Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Lansky or Karnofsky Performance Status, Histology of Cancer, Disease Status at Enrollment, Prior Therapy, Peripheral Absolute Neutrophil Count, Platelet Count, Hemoglobin, Creatinine Clearance or Radioisotope Glomerular Filtration Rate, Total Bilirubin, SGPT (ALT), PT, PTT, INR, Serum Lipase, Serum Amylase, Blood Pressure, Pulse Oximetry.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Lansky or Karnofsky Performance Status",
        "Histology of Cancer",
        "Disease Status at Enrollment",
        "Prior Therapy",
        "Peripheral Absolute Neutrophil Count",
        "Platelet Count",
        "Hemoglobin",
        "Creatinine Clearance or Radioisotope Glomerular Filtration Rate",
        "Total Bilirubin",
        "SGPT (ALT)",
        "PT",
        "PTT",
        "INR",
        "Serum Lipase",
        "Serum Amylase",
        "Blood Pressure",
        "Pulse Oximetry"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, Lansky or Karnofsky performance status score, diagnosis (rhabdomyosarcoma, Wilms tumor, hepatocellular carcinoma, papillary thyroid carcinoma), relapsed or refractory disease status, radiographically measurable disease status, prior treatment history (chemotherapy, radiation therapy, immunomodulating agents, other investigational agents), peripheral absolute neutrophil count (ANC), platelet count, hemoglobin, creatinine clearance or radioisotope glomerular filtration rate (GFR), total bilirubin, SGPT (ALT), PT, PTT, INR, serum lipase and amylase, blood pressure (BP), pulse oximetry.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Lansky or Karnofsky performance status score",
        "diagnosis (rhabdomyosarcoma, Wilms tumor, hepatocellular carcinoma, papillary thyroid carcinoma)",
        "relapsed or refractory disease status",
        "radiographically measurable disease status",
        "prior treatment history (chemotherapy, radiation therapy, immunomodulating agents, other investigational agents)",
        "peripheral absolute neutrophil count (ANC)",
        "platelet count",
        "hemoglobin",
        "creatinine clearance or radioisotope glomerular filtration rate (GFR)",
        "total bilirubin",
        "SGPT (ALT)",
        "PT",
        "PTT",
        "INR",
        "serum lipase and amylase",
        "blood pressure (BP)",
        "pulse oximetry"
      ]
    }
  }
}